Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M GELFAND

Showing results (461-470 of 889) with videos related to

Pageof 89
Sort By:
Menopause (New York, N.Y.)|May 16, 2000
17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitisJ E Rioux, C Devlin, M M Gelfand, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 5, 2021
Neurosarcoidosis: Pathophysiology, Diagnosis, and TreatmentMichael J Bradshaw, Siddharama Pawate, Laura L Koth, et al.
The American Journal of Tropical Medicine and Hygiene|September 1, 1970
Schistosomiasis of the male pelvic organs. Severity of infection as determined by digestion of tissue and histologic methods in 300 cadaversM Gelfand, C M Ross, D M Blair, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2004
Rho overexpression leads to mitosis-associated detachment of cells from epithelial sheets: a link to the mechanism of cancer disseminationJ M Vasiliev, T Omelchenko, I M Gelfand, et al.
Climacteric : the Journal of the International Menopause Society|April 27, 2002
Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 beta-estradiol combined with sequential 5-20 mg dydrogesteroneA Ferenczy, M M Gelfand, P H M van de Weijer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 2, 2021
CoachMS, an innovative closed-loop, interdisciplinary platform to monitor and proactively treat MS symptoms: A pilot studyValerie J Block, Arpita Gopal, William Rowles, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMOJeffrey M Gelfand, Jennifer Cotter, Jeffrey Klingman, et al.
International Journal of Cancer|July 15, 1976
Serum dependence of expression of the transformed phenotype: experiments with subline of mouse L fibroblasts adapted to growth in serum-free mediumA D Bershadsky, T Hamaoka, V I Guelstein, et al.
Nanotechnology|August 29, 2020
Nanoaperture fabrication in ultra-smooth single-grain gold films with helium ion beam lithographyChenyi Zhang, Jinxin Li, Alex Belianinov, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Rho-dependent formation of epithelial "leader" cells during wound healingT Omelchenko, J M Vasiliev, I M Gelfand, et al.
Pageof 89

Showing results (461-470 of 889) with videos related to

Sort By:
Pageof 89
Menopause (New York, N.Y.)|May 16, 2000
17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitisJ E Rioux, C Devlin, M M Gelfand, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 5, 2021
Neurosarcoidosis: Pathophysiology, Diagnosis, and TreatmentMichael J Bradshaw, Siddharama Pawate, Laura L Koth, et al.
The American Journal of Tropical Medicine and Hygiene|September 1, 1970
Schistosomiasis of the male pelvic organs. Severity of infection as determined by digestion of tissue and histologic methods in 300 cadaversM Gelfand, C M Ross, D M Blair, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2004
Rho overexpression leads to mitosis-associated detachment of cells from epithelial sheets: a link to the mechanism of cancer disseminationJ M Vasiliev, T Omelchenko, I M Gelfand, et al.
Climacteric : the Journal of the International Menopause Society|April 27, 2002
Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 beta-estradiol combined with sequential 5-20 mg dydrogesteroneA Ferenczy, M M Gelfand, P H M van de Weijer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 2, 2021
CoachMS, an innovative closed-loop, interdisciplinary platform to monitor and proactively treat MS symptoms: A pilot studyValerie J Block, Arpita Gopal, William Rowles, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMOJeffrey M Gelfand, Jennifer Cotter, Jeffrey Klingman, et al.
International Journal of Cancer|July 15, 1976
Serum dependence of expression of the transformed phenotype: experiments with subline of mouse L fibroblasts adapted to growth in serum-free mediumA D Bershadsky, T Hamaoka, V I Guelstein, et al.
Nanotechnology|August 29, 2020
Nanoaperture fabrication in ultra-smooth single-grain gold films with helium ion beam lithographyChenyi Zhang, Jinxin Li, Alex Belianinov, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2003
Rho-dependent formation of epithelial "leader" cells during wound healingT Omelchenko, J M Vasiliev, I M Gelfand, et al.
Pageof 89